170 related articles for article (PubMed ID: 28452863)
1. Efficacy and Factors Associated with Treatment Response of Intravenous Immunoglobulin in Inpatients with Refractory Inflammatory Bowel Diseases.
Horton N; Kochhar G; Patel K; Lopez R; Shen B
Inflamm Bowel Dis; 2017 Jul; 23(7):1080-1087. PubMed ID: 28452863
[TBL] [Abstract][Full Text] [Related]
2. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
Solanky D; Pardi DS; Loftus EV; Khanna S
Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
[TBL] [Abstract][Full Text] [Related]
3. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
[TBL] [Abstract][Full Text] [Related]
4. Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments.
Merkley SA; Beaulieu DB; Horst S; Duley C; Annis K; Nohl A; Schwartz DA
Inflamm Bowel Dis; 2015 Aug; 21(8):1854-9. PubMed ID: 25993689
[TBL] [Abstract][Full Text] [Related]
5. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
[TBL] [Abstract][Full Text] [Related]
7. Management of inflammatory bowel disease with
D'Aoust J; Battat R; Bessissow T
World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
[TBL] [Abstract][Full Text] [Related]
8. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
Li Y; Qian J; Queener E; Shen B
Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors.
Banaszkiewicz A; Kowalska-Duplaga K; Pytrus T; Pituch H; Radzikowski A
Inflamm Bowel Dis; 2012 May; 18(5):844-8. PubMed ID: 21936029
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection and inflammatory bowel disease.
Cojocariu C; Stanciu C; Stoica O; Singeap AM; Sfarti C; Girleanu I; Trifan A
Turk J Gastroenterol; 2014 Dec; 25(6):603-10. PubMed ID: 25599768
[TBL] [Abstract][Full Text] [Related]
13. Systematic review: Clostridium difficile and inflammatory bowel disease.
Goodhand JR; Alazawi W; Rampton DS
Aliment Pharmacol Ther; 2011 Feb; 33(4):428-41. PubMed ID: 21198703
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and management of refractory or recurrent clostridium difficile infection in ileal pouch patients.
Seril DN; Ashburn JH; Lian L; Shen B
Inflamm Bowel Dis; 2014 Dec; 20(12):2226-33. PubMed ID: 25222656
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.
Regnault H; Bourrier A; Lalande V; Nion-Larmurier I; Sokol H; Seksik P; Barbut F; Cosnes J; Beaugerie L
Dig Liver Dis; 2014 Dec; 46(12):1086-92. PubMed ID: 25294795
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis.
Navaneethan U; Mukewar S; Venkatesh PG; Lopez R; Shen B
J Crohns Colitis; 2012 Apr; 6(3):330-6. PubMed ID: 22405170
[TBL] [Abstract][Full Text] [Related]
19. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.
Ananthakrishnan AN; McGinley EL; Binion DG
Gut; 2008 Feb; 57(2):205-10. PubMed ID: 17905821
[TBL] [Abstract][Full Text] [Related]
20. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
